Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
| NCT ID | NCT05827614 |
| Title | Study of the CHK1 Inhibitor BBI-355, an ecDNA-directed Therapy, in Subjects With Tumors With Oncogene Amplifications (POTENTIATE) |
| Acronym | POTENTIATE |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | Boundless Bio |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Sarcoma Oncology | RECRUITING | Santa Monica | California | 90403 | United States | Details |
| START Midwest | RECRUITING | Grand Rapids | Michigan | 49546 | United States | Details |
| Memorial Sloan Kettering Cancer Center | RECRUITING | New York | New York | 10065 | United States | Details |
| MD Anderson Cancer Center | RECRUITING | Houston | Texas | 77054 | United States | Details |
| NEXT Oncology | RECRUITING | San Antonio | Texas | 78229 | United States | Details |
| NEXT Oncology | RECRUITING | Fairfax | Virginia | 22031 | United States | Details |